It is estimated that as many as three out of ten people globally have MASLD, previously called non-alcoholic fatty liver ...

Pregnant women with metabolic dysfunction-associated steatotic liver disease (MASLD) have an increased risk of giving birth ...

Pregnant women with metabolic dysfunction-associated steatotic liver disease (MASLD) have an increased risk of giving birth prematurely and the risk increase cannot be explained by obesity, according ...

At the moment, there is a lack of clinically relevant preclinical models for fatty liver disease. This problem has led to most drug candidates that were successful in preclinical development ...

Pregnant women with MASLD have over three times the risk of preterm birth, according to Swedish registry data. This risk ...

Hepatic steatosis, also known as fatty liver disease, is the accumulation of extra fat in liver cells, frequently as a result of unhealthy lifestyle choices. Although the illness is typically ...

The cutting-edge weight-loss drug Ozempic/Wegovy can stop and even reverse fatty liver disease, a new clinical trial has found. Nearly twice as many people taking semaglutide stopped their fatty ...

Treating anemia during pregnancy might lower the risk of heart defects in newborns, a new study says. Women with anemia in ...